Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-06-15
1995-06-20
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540451, C07D28100, C07D26700, A61K 31395
Patent
active
054261031
ABSTRACT:
The invention relates to macrocyclic lactam derivatives of formula I ##STR1## wherin R is hydrogen or acyl; m is an integer from 4 to 9 inclusive; n is 1 or 2; p is zero, 1 or 2; X is --CONH-- or --NHCO--; Y is S, O or CH.sub.2 ; R.sub.1 is --COOH; or R.sub.1 is ##STR2## in which R.sub.2 is hydrogen, lower alkyl, aryl-lower alkyl, amino-lower alkyl, hydroxy-lower alkyl, acyloxy-lower alkyl, lower alkoxy-lower alkyl, mercapto-lower alkyl, lower alkyl-(thio, sulfinyl or sulfonyl)-lower alkyl, or carboxy-lower alkyl, R.sub.3 is hydrogen or lower alkyl, and q is zero or an integer from 1 to 5 inclusive; or R.sub.1 is ##STR3## in which R.sub.4 is hydrogen, lower alkyl, lower alkoxy, hydroxy or acyloxy, and r is 1 or 2; or R.sub.1 is ##STR4## in which s is 1 or 2; or R.sub.1 is ##STR5## in which R.sub.5 and R.sub.6 independently represent hydrogen, lower alkyl, C.sub.5 - or C.sub.6 -cycloalkyl, (hydroxy-, acyloxy or lower alkoxy-) lower alkyl, carbocyclic or heterocyclic monocyclic aryl, or (hydroxy-, acyloxy- or alkoxy-) lower alkyloxy-lower alkyl; or R.sub.5 and R.sub.6 together with the nitrogen to which they are attached represent pyrrolidino, piperidino, morpholino, piperazino or N-alkylpiperazino; and macrocyclic sulfur and oxygen containing lactam ring isomers in which a CH.sub.2 group of (CH.sub.2).sub.m in formula I is is replaced by O or S, and Y represents CH.sub.2 ; and pharmaceutically acceptable prodrug esters of any above said compound with a free carboxyl group; and pharmaceutically acceptable salts of any said compounds with a free acid or basic salt forming group; pharmaceutical compositions comprising said compounds; methods for the preparation of said compounds and for the preparation of intermediates; and methods of treating disorders in mammals which are responsive to the inhibition of neutral endopeptidases by administration of said compounds to mammals in need of such treatment.
REFERENCES:
patent: 5075302 (1991-12-01), Neustadt
patent: 5095110 (1992-03-01), Flynn et al.
Bichemical Biophys. Res. Comm., vol. 111, 166 (1983) (Bill).
J. Am. Chem. Soc., vol. 112, 327 (1990).
Medicinal Research Reviews, vol. 5, No. 4, pp. 483-531 (1985).
Trends Pharmacol Sci., vol. 11, No. 6, 1990 pp. 245-249.
Fidia Research Foundation Symposium Series, vol. 2, 1989, pp. 47-54.
Clinical Nephrology, vol. 36, No. 4, 1991 pp. 187-191 Sybertz.
J. Med. Chem., vol. 27, 816 (1984).
MacPherson Lawrence J.
Stanton James L.
Bond Robert T.
Ciba-Geigy Corporation
Gruenfeld Norbert
LandOfFree
Certain macrocyclic lactam derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain macrocyclic lactam derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain macrocyclic lactam derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1844246